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Background: The use of herbal medicines is global, with the majority of the world’s population depending on 
traditional medicines, particularly herbal remedies for their primary healthcare needs. In Kenya, it is estimated that 
conventional healthcare system provides for approximately 30 % of the population, while nearly 70 % rely on herbal 
remedies. Herbal medicines, however, present safety concerns as they carry a relatively high risk of contamination by 
pathogenic microbes, organic and inorganic pollutants including toxic metals and non-metals, organic, mycotoxins, 
endotoxins, and agrochemical residues.  
Objective: This study was designed to assess the microbial quality of regulated and unregulated herbal medicinal 
products in diverse Kenyan markets, such as the supermarkets, roadside vendors, retail pharmacies and herbal 
clinics, for levels of microbial contaminants. 
Materials and Methods: Thirty samples of registered and unregistered herbal medicinal products were collected by 
purposive sampling from five Kenyan provinces.  Microbial load analysis was performed in accordance to 
pharmacopoeial methods (BP and USP). Microorganisms were further isolated and characterized using differential 
and selective media and by biochemical analyses.  
Results: All registered products had microbial load below 100 cfu/ml, and complied with BP and USP requirements. 
However, none of the unregistered samples complied with pharmacopoeial limits for either or both bacterial and 
fungal load limits. Most of the unregistered samples had microbial loads ranging from 3.00×106 to 1.56 × 1010 cfu/ml, 
thus exceeding by far BP or USP standards. The microbial isolates belonged to fifteen (15) different bacterial genera 
and seven (7) fungal genera.  Escherichia coli was the most frequently isolated bacteria from 75 % of the unregistered 
product samples while Klebsiella pneumoniae, Enterobacter aerogenes, and Staphylococcus aureus followed in 70 %, 60 
% and 45 % of the samples, respectively. Salmonella spp was isolated in 40 % of the samples while Shigella spp was 
found in 20 % of the samples.  
Conclusion: Unregulated herbal medicinal products that are available in diverse Kenyan markets show poor 
microbial quality and exhibit contamination by pathogenic microorganisms.  There is need to extend regulatory 
control by the drug authorities to herbal medicinal products to enhance microbial quality and safety.  
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1. Introduction 
The majority of the world’s population depends on 
traditional medicines, particularly herbal remedies for 
their primary healthcare needs (WHO, 2008; Akerele, 
1993). In Kenya, it is estimated that conventional 
healthcare system provides for approximately 30 % of 
the population, while nearly 70 % rely on herbal 
remedies (NCPAD, 2007). Furthermore, medical 
pluralism is widespread in Kenya, with patients seeking 
both conventional and alternative medicine therapies 
(Kigen et al., 2013).  Indeed the complementary 
medicine practitioner: patient ratio is much higher than 
the conventional doctor: patient ratio (Mwangi et al, 
2005). Such widespread use of herbal medicines, calls 
for the assurance of sustainable availability of quality 
and safe herbal medicines to ensure continued access 
especially for rural communities, without compromising 
patient safety (Kigen et al, 2013).   
Herbal medicines present safety concerns as  they carry 
a relatively high risk of contamination by pathogenic 
microbes, organic and inorganic residues including 
toxic metals and non-metals, organic pollutants, 
mycotoxins, endotoxins, and agrochemical residues 
(Okunlola et al, 2007; Abba et al, 2009; de Freitas 
Araújo and and Bauab, 2012).  
In Kenya, the competent authority responsible for 
regulating the safety and efficacy of pharmaceutical 
products is the Pharmacy and Poisons Board (PPB).  
Products for which any medicinal claims are made must 
be granted marketing authorization by the PPB, which 
ensures that registered products are manufactured in 
compliance with Good Manufacturing Practices (GMP), 
amongst other criteria. The majority of herbal products 
marketed to members of the public in Kenya are not 
regulated by the PPB as they are categorized as 
traditional or cultural remedies whose mode of 
utilization predate modern regulation, and they thus 
enjoy regulatory exemption. The few manufacturers of 
herbal remedies, who register their products with the 
PPB, mostly do so to access the conventional medicine 
market through doctors’ prescribing and the retail 
pharmacies.  
This study was therefore designed to assess the 
microbial quality of regulated and unregulated herbal 
medicinal products in diverse Kenyan markets, such as 
the supermarkets, roadside vendors, retail pharmacies 
and herbal clinics, for levels of microbial contaminants. 
2. Materials and Methods 
2.1 Collection of Samples 
A list of the herbal products that are registered by the 
Pharmacy and Poisons Board was obtained from the 
regulatory authority. The total number of registered 
products was fifty-four, out of which 10 were readily 
available in retail pharmacies or supermarkets. All 10 
available products were purchased.    Twenty samples 
of unregistered herbal products were collected by a 
purposive sampling technique from five Kenyan 
provinces, namely: Nairobi, Central, Rift Valley, Nyanza 
and Western provinces. The samples were obtained 
from herbal clinics, supermarkets and road side 
vendors.  The non-packaged samples were collected in 
sterile polythene containers. Thus a total 30 samples, in 
both liquid and powder formulations were subjected to 
analysis for this study. 
2.2 Microbiological Analyses 
Media preparation 
All samples were analyzed at the National Quality 
Control Laboratory for Drugs and Medical Devices, 
Nairobi,  Kenya.   
Bacteriological and fungal media were supplied by 
Himedia Laboratories (India). Media in powder form 
were weighed, reconstituted with distilled water, 
heated to completely dissolve the medium, and 
sterilized by autoclaving at 115 kPa, 121 °C for 15 min.   
The following media were used: Nutrient Agar, 
Sabouraud Dextrose Agar (SDA), MacConkey Agar, 
Eosin-Methylene Blue (EMB) Agar, Salmonella Shigella 
Agar (SSA), Xylose-Lysine Deoxycholate (XLD) Agar and 
Mannitol Salt Agar. 
All media were tested for viability using Bacillus 
pumilus NC08241, Staphylococcus aureus NC07447, 
Pseudomonas aeruginosa NC12924, Saccharomyces 
cerevisiae NC010716, Candida albicans NC10400, and  
Aspergillus niger NCPF3179.  All standard strains of 
microorganisms were obtained from National Collection 
of Type Cultures (NCTC), United Kingdom. 
Sample preparation  
For water soluble samples, 1 g or 1 ml of the herbal 
product was dissolved in 10 ml buffered peptone water, 
pH 7.0, followed by tenfold serial dilution.  For 
lipophillic products, 1 g or 1 ml of sample was 
homogenized with 0.5 ml of polysorbate 20 and heated 
to 40 °C in a water bath followed by addition of 10 ml of 
buffered peptone water, mixing for 15 min, and then 
followed by 10 -1 serial dilutions.  
Isolation of pure colonies 
Colonies were isolated based on morphologic 
differences from their axenic cultures.  Colony form, 
elevation, pigmentation and size were the major 
distinguishing characteristics.  Petri-dishes were 
divided to quadrants and sub-culturing done by the 
streak plate technique (Holt et al, 1994). 
Microscopy 
One loopful of bacteria culture was applied on a clean 
labeled microscope slide. The smear was heat fixed on 
the slide by passing it over a flame of the Bunsen 
burner, and Gram-stained according to Preston and 
Morel (1962).  The smear was blot dried before viewing 
under the oil immersion objective (X1000) lens. 
2.3 Test for specific microbes using differential 
and selective media 
Specific microorganisms were tested using differential 
and selective media as follows: 
Staphylococcus aureus. A pure culture from Nutrient 
Agar was sub-cultured on a plate of mannitol salt agar 
freshly prepared as per the manufacturer’s details. It 
was incubated at 33 °C for 72 h. Growth of white 
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colonies surrounded by yellow zones indicated the 
presence of Staphylococcus aureus and was confirmed 
by Gram staining and biochemical tests. 
Escherichia coli. A pure culture from Nutrient Agar was 
inoculated into Eosin Methylene Blue agar. The 
innoculum was incubated at 33 °C for 72 h. Colonies 
with dark centers and greenish metallic sheen indicated 
the presence of lactose fermenters. E. coli was 
confirmed by  biochemical tests. 
Salmonella spp. A pure culture from Nutrient Agar was 
inoculated into Xylose Lysine Desoxycholate agar. It was 
then incubated at 33 °C for 48 h. Growth of well 
developed red colonies with black centers was 
considered to be the presence of salmonella spp. They 
were further subjected to biochemical tests for 
confirmation. 
Klebsiella pneumonia. A pure culture from Nutrient 
Agar was inoculated into MacConkey agar. It was then 
incubated at 33 °C for 72 h. growth of round mucoid 
colonies with colorless edges was considered to be the 
presence of Klebsiella pneumonia which were further 
subjected to biochemical tests for confirmation. 
Enterobacter aerogenes. A pure culture from Nutrient 
Agar was inoculated into Eosin Methyhlene Blue. It was 
then incubated at 33 °C for 72 h. Growth of pinkish large 
mucoid colonies was considered to be the presence of 
Enterobacter aerogene. Further biochemical tests were 
done for confirmation. 
Shigella spp. A pure culture from Nutrient Agar was 
inoculated into Shigella Salmonella agar. It was 
incubated at 33 °C for 72 h. growth of mucoid colonies 
with black centers was considered to be the presence of 
Shigella spp. A further subjection to biochemical tests 
was done for confirmation. 
Candida spp. A pure culture isolated in Sabouraud 
Dextrose Broth was inoculated into Sabouraud Dextrose 
Agar. It was incubated at 25 °C for 5 days. Growth of 
small round moist, white to colorless colonies with even 
edges was considered to be the presence of Candida 
spp. Further microscopic studies were done for 
confirmation. 
2.4 Biochemical Analyses 
Biochemical analyses were performed with the API 20 E 
system (bioMérieux, France) which tests nitrate 
reduction, indole production from tryptophan, presence 
of urease, arginine dihydrolase, β-galactosidase, β-
glucosidase, cytochrome oxidase, protease, glucose 
fermentation and assimilation   of L-tryptophan,  
sodium pyruvate, gelatin,  D-glucose, D-mannitol, 
Inositol, D-sorbitol, L-rhamnose, D-sucrose, D-
melibiose, Amygdalin, and L-arabinose. 
Analyses with the API 20 E system were performed 
according to the manufacturer’s instructions. Briefly the 
API 20 E strip was prepared by distributing 1 ml of 
distilled water into the honeycombed wells of the tray 
to create a humid atmosphere. The inoculum was 
suspended in 5 ml of 0.85 % Nacl. Anaerobiosis was 
created in the tests for arginine dihydrolase (ADH), 
lysine decarboxylase (LDC), ornithine decarboxylase 
(ODC), H2S production and urea hydrolysis (URE) by 
overlaying with mineral oil. Samples were incubated at 
37 °C for 24 h. The strips were read using a color chart 
provided by the manufacturer.  
The oxidase test was done by using oxidase discs 
(Himedia laboratories, India) for detection of oxidase 
production. Isolated colonies were applied on oxidase 
discs and observed within 10 sec. at room temperature 
(25 °C) for change in colour. 
The microorganisms were identified based on a 
numerical taxonomy profile according to the 
manufacturer’s chart (bioMérieux, France, available at 
http://www.biomeriux.com).  
2.5 Molecular Analyses and Identification  
Bacterial genomic deoxyribonucleic acid (DNA) was 
isolated from plate cultures using a modified alkaline 
lysis method as described in Osanjo et al (2009).  The 
16S rDNA was amplified using the primer pair F27 (5’- 
AGAGTTTGATCCTGGCTCAG-3’) and R1492 (5’- 
TACGGYTACCTTACGACTT-3’) that amplifies bacterial 
16S rDNA from position 27 to 1492 in the E. coli 
numbering system. The primers were supplied by MWG 
Biotech (Germany). Polymerase chain reaction (PCR) 
amplifications were performed in a thermal cycler 
(GeneAmp PCR systems 9700, Applied Biosystems USA) 
under the conditions described previously (Osanjo et al, 
2009). The amplification products were purified from 
agarose gel using the QIAXEX II extraction kit (Qiagen, 
USA) according to the manufacturer’s method. 
Purified 16S rDNA was sequenced with the PCR primers 
(F27 and R1492) in the forward and reverse directions, 
in a Perkin-Elmer fluorescent dye-labelled 
dideoxynucleotides (Perkin-Elmer, USA) by the 
Sequencing Unit (Segolip) of the International Livestock 
Research Institute (ILRI, Kenya). 
3. Results  
The results of the microbiological analyses are 
summarized in Table 1.   
Two samples, KM and MB, had an average total aerobic 
microbial count of 6.0 × 105 and 6.50 × 105 cfu/ ml 
respectivel, thus complying with the BP and USP limits 
for bacterial loads (BP, 2007 and USP-NF 2009). 
However even though these samples complied with 
bacterial load limits, their fungal loads were 
nonetheless higher than pharmacopoeial limits.  The 
rest of the unregistered samples had a microbial loads 
ranging from 3.00×106 to 1.56 × 1010 cfu/ml, and did not 
comply with BP or USP standards. All registered 
products had microbial load below 100 cfu/ml, and 
therefore complied to BP and USP requirements. 
The microbial isolates belonged to fifteen (15) different 
bacterial genera and seven (7) fungal genera.  
Escherichia coli was the most frequently isolated 
bacteria from 75 % of the unregistered product samples 
while Klebsiella pneumoniae, Enterobacter aerogenes, 
and Staphylococcus aureus followed in 70 %, 60 % and 
45 % of the samples respectively. Salmonella spp was 
isolated in 40 % of the samples while Shigella spp was 
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in 20 %. The rest of the bacteria were isolated from less 
than 10 % of the samples. 
Candida spp formed the major fungal isolate from 50 % 
of the samples followed by Fusarium and Aspergillus 
species which were in 35 and 25 % of the samples, 
respectively. Rhizopium spp was isolated from 20 % of 
the samples while the rest of the fungal species were 
isolated from less than 10 % of the samples. 
 
Table 1: Microbial Counts for Unregistered Herbal medicinal samples obtained from Kenya 
Key: * E. Coli - Escherichia coli; † E. aerogenes - Enterobacter aerogenes 
4. Discussion  
All unregulated herbal medicinal products did not 
comply with the BP standards for microbial quality.  
The limits for microbial contamination by the BP for 
aerobic microbial and fungal counts for herbal products 
to which boiling water is added before use are not more 
than 107 and 105 cfu/g, respectively. Salmonella and 
Escherichia coli and should also be absent according to 
BP specifications.   The unregulated herbal medicinal 
products therefore did not meet these pharmacopoeial 
specifications.  
The majority of the samples contained pathogenic 
bacterial contaminants.  Escherichia coli which 
contaminated 75 % of the samples is a well known 
enteropathogen, and is the most common causative 
agent of childhood diarrhea of bacterial origin 
(Bonkoungou  et al, 2013). E. coli is also used as a 
marker of fecal contamination in standard assays of 
water and food (APHA, 1992; Jay, 1997).  
The high levels of microbial contamination observed in 
this study may be attributed to the methods of their 
preparation.  Personnel could introduce 
microorganisms to the products during handling of the 
raw materials and packaging of products.  Abba et al 
(2009) have also suggested that unhygienic equipment 
and materials could also be a source of microbial 
contaminants.  Good Manufacturing Practices are 
therefore required throughout the process of 
Sample 
Code 
Aerobic Microbial 
Count (cfu/ml) 
Fungal Count 
(cfu/ml) 
Microorganism identified 
AD 3.00×106 5.20×106 Klebsiella pneumonia, Chryseomonas luteola, Aspergillus sp. 
BP 2.61×107 2.04×107 Klebsiella oxytoca, Enterobacter cloacae, Candida sp. 
CS 1.21×107 1.00×107 Staphylococcus aureus, *E. coli, Rhizopium sp. Fusarium sp., B. subtillis 
DF 2.50×107 1.84×106 S. aureus,  K. pneumonia, E. coli, Enterobacter aerogenes, Salmonella sp 
GI 2.08×107 2.23×107 Enterobacter aerogenes, K. pneumonia, E. coli, Aspergillus Sp. Fusarium 
GS 1.56×1010 1.07×107 E. coli, K. pneumonia, †E. aerogenes Fusarium sp. Aspergillus sp. 
Rhizopus sp., Baccillus safensis 
HB 1.03×1010 8.1×10⁸ S. aureus, K. pneumonia, E. coli, E. aerogenes, Salmonella Sp, Candida sp.   
Aspergillus sp, Torula sp, Bacillus flexus 
KC 1.01×107 2.05×107 Salmonella sp. Enterobacter aerogenes, Candida sp. 
KD 1.56×109 1.48×107 Staphylococcus aureus, E. coli, Candida sp., Fusarium sp. 
KH 2.14×107 1.14×107 K.  pneumonia, Enterobacter aerogenes, E. coli, Candida sp.  Torula sp 
KM 6.00×105 5.30×104 S. aureus, K. pneumonia, E. coli, E. aerogenes, Salmonella sp. Shigella sp. 
Candida sp. Serratia marsenses, Kocuria rosea  
MB 6.50×105 5.40×105 Klebsiella pneumonia, E. coli, Fusarium sp. 
MC 2.50×107 6.80×107 K. pneumonia, E. coli, Rhizopus sp. Candida sp. Penicillium sp, Torula sp. 
MH 1.50×1010 5.40×106 K. pneumonia, E. coli, E. aerogenes, salmonella sp, Shigella sp, Candida 
sp, Enterobacter agglomerurans, Flavobacterium sp,  Enterobacter 
cloacae 
MS 2.50×107 7.10×106 S. aureus, K. pneumonia, E. aerogenes, Salmonella sp., Penicillium sp. 
MW 2.94×107 2.63×107 K. pneumonia, E. coli, Enterobacter aerogenes, Fusarium sp. 
NE 1.80×109 1.56×109 S. aureus, K. pneumonia, E. coli, E. aerogenes, Salmonella sp, Shigella sp, 
Candida sp. Pseudomonas aeruginosa., Bacillus pumillis 
NP 3.6×106 5.00×105 Staphylococcus aureus, Salmonella, Aspergillus sp. Fusarium sp. 
ST 2.73×107 2.07×107 E. coli, Candida sp. Penicillium sp. 
US 1.66×107 1.86×107 S. aureus,  K. pneumonia, E. coli, E. aerogenes, Salmonella sp, Shigella sp 
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harvesting, drying, storage, handling and preparation of 
the herbal medicinal product. 
Other potential pathogenic microorganisms isolated 
from the samples included: Salmonella spp, Klebsiella 
pneumoniae, Pseudomomas aeuroginosa, Enterobacter 
aerogenes, and Staphylococcus aureus. Staphylococcus 
aureas, for example has been associated with a number 
of complications especially to immune-compromised 
individuals. It can produce proteins that disable the 
immune system and damage tissues. It may also release 
exotoxins which cause gastroenteritis (Lowy, 1998).  
The finding of other potential pathogens may also be 
significant. 
Klebsiella pneumonia, a Gram negative lactose 
fermenting bacterium found in the normal flora of the 
mouth is ranked second from E. coli for urinary tract 
infections in older people and is also an opportunistic 
infection of people with weakened immunity. It also 
commonly causes pneumonia (Nordmann and Naas, 
2009). Pseudomonas aeruginosa is a notorious cause of 
nosocomical infections, and may cause life threatening 
illness in immune compromised individuals (Van 
Eldere, 2003). 
Salmonella spp is clinically relevant as it may cause 
typhoid, a disease that is a public health concern in 
Kenya (Kariuki, 2010).  
The presence of moulds such as Penicillium spp, 
Candida spp and Aspergillus spp are of additional 
concern. Both Penicillium spp and Aspergillus spp are 
associated with food poisoning and may be responsible 
for infections particularly in immunocompromised 
individuals (Lin, 2001; Bateman, 2002). Penicillium spp 
has been isolated from solids and liquid herbal products 
in a study by Esimone et al. (2007). In addition 
Penicillium spp produces the mycotoxin, ochratoxin A, 
which is both nephrotoxic and carcinogenic (Burge 
1989). 
5. Conclusion  
This study has showed that unregulated herbal 
medicines marketed in Kenya are highly contaminated 
with microorganisms, some of which are pathogenic.  
Such unregulated medicinal products may facilitate 
transmission of communicable diseases in the 
population and therefore present a public health 
problem. 
There is consequently need to extend government 
regulation to herbal medicinal products to ensure that 
their processing, preparation or manufacture comply 
with Good Manufacturing Practices, and thus lessen 
risks to consumers and patients. 
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